David A Spellman - Net Worth and Insider Trading
David A Spellman Net Worth
The estimated net worth of David A Spellman is at least $866,177 dollars as of 2024-11-10. David A Spellman is the SVP, CFO and Treasurer of Akebia Therapeutics Inc and owns about 446,483 shares of Akebia Therapeutics Inc (AKBA) stock worth over $866,177. Details can be seen in David A Spellman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David A Spellman has not made any transactions after 2023-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David A Spellman
David A Spellman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David A Spellman owns 2 companies in total, including Akebia Therapeutics Inc (AKBA) , and Mersana Therapeutics Inc (MRSN) .
Click here to see the complete history of David A Spellman’s form 4 insider trades.
Insider Ownership Summary of David A Spellman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2023-05-16 | SVP & CFO and Treasurer |
| MRSN | Mersana Therapeutics Inc | 2018-03-12 | Chief Financial Officer |
David A Spellman Latest Holdings Summary
David A Spellman currently owns a total of 1 stock. David A Spellman owns 446,483 shares of Akebia Therapeutics Inc (AKBA) as of May 16, 2023, with a value of $866,177.
Latest Holdings of David A Spellman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2023-05-16 | 446,483 | 1.94 | 866,177 |
Holding Weightings of David A Spellman
David A Spellman Form 4 Trading Tracker
According to the SEC Form 4 filings, David A Spellman has made a total of 4 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 63,567 shares on May 16, 2023, which brought David A Spellman around $68,017.
Insider Trading History of David A Spellman
- 1
David A Spellman Trading Performance
David A Spellman Ownership Network
Ownership Network List of David A Spellman
Ownership Network Relation of David A Spellman
David A Spellman Owned Company Details
What does Akebia Therapeutics Inc do?
Who are the key executives at Akebia Therapeutics Inc?
David A Spellman is the SVP & CFO and Treasurer of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Business Officer Michel Dahan , SVP & General Counsel & Sec. Nicole R. Hadas , and director & CEO & President John P. Butler .
Akebia Therapeutics Inc (AKBA) Insider Trades Summary
Over the past 18 months, David A Spellman made 1 insider transaction in Akebia Therapeutics Inc (AKBA) with a net sale of 63,567. Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 149,723 shares made by Michel Dahan , a net sale of 106,103 shares made by Steven Keith Burke , and a net sale of 88,587 shares made by Nicole R. Hadas .
In summary, during the past 3 months, insiders sold 0 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 492,283 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 492,283 shares.
Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akebia Therapeutics Inc Insider Transactions
David A Spellman Mailing Address
Above is the net worth, insider trading, and ownership report for David A Spellman. You might contact David A Spellman via mailing address: 840 Memorial Drive, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
